Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Syngenta 4Q profit falls as raw material prices increase

by Staff GBAF Publications Ltd
0 comment

ZURICH (Reuters) – Swiss agrichemicals and seeds group Syngenta on Wednesday reported a 25% drop in fourth quarter earnings due to higher raw materials and energy costs.

Syngenta, which plans to list within the next few months, also spent more on reorganising its business and set cash aside to cover macro-economic uncertainties such as further raw material spikes or potential bad debts by customers.

The Chinese-owned company said its earnings before interest, tax, depreciation and amortisation (EBITDA) dropped 25% to $900 million in the three months to the end of December.

Sales rose 4% to $7.5 billion boosted by strong growth in its seeds business.

“As previously indicated, farmers accelerated their purchases earlier in the year due to supply concerns, moderating fourth quarter growth,” the company said.

“The group continued to maintain higher prices necessary to offset elevated raw material and other costs,” it added.

During 2022 Syngenta’s sales increased 19% to $33.4 billion while EBITDA rose 20% to $5.6 billion.

Much of the growth came from China, where the company added 136 more MAP training and sales centres to take its total to 628 sites.

Syngenta, which competes with U.S. company Corteva and Germany’s BASF and Bayer, was bought in 2017 for $43 billion by ChemChina, which was folded into Sinochem Holdings Corp in 2021.

The parent company plans to keep a majority stake after its $10 billion flotation, which is expected to value Syngenta at around $50 billion.


(Reporting by John Revill; editing by John O’Donnell)